marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Capricor Therapeutics Balance Sheet 2011-2024 | CAPR
Annual Balance Sheet Capricor Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-12.5 M | -7.04 M | -32 M | -32.3 M | -523 K | -883 K | -6.14 M | 23.7 M | 11.6 M | 1.12 M | 2.56 M | -46.7 K | -1.04 M |
Long Term Debt |
1.49 M | 1.88 M | 2.45 M | 71.5 K | - | - | - | 13.9 M | 9.16 M | 9.16 M | 3.96 M | - | - |
Long Term Debt Current |
749 K | 682 K | 418 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
4.86 M | 14.7 M | 5.83 M | 3.45 M | 3.38 M | 3.38 M | 3.38 M | 17.9 M | 10.6 M | 13.6 M | 4.02 M | 63.4 K | - |
Total Current Liabilities |
31.3 M | 23.6 M | 4.13 M | 2.97 M | 898 K | 1.26 M | 1.67 M | 4.9 M | 6.53 M | 6.3 M | 2.05 M | 331 K | 541 K |
Total Liabilities |
36.1 M | 38.3 M | 9.96 M | 6.42 M | 4.27 M | 4.63 M | 5.05 M | 22.8 M | 17.1 M | 19.9 M | 6.07 M | 394 K | 541 K |
Deferred Revenue |
24.3 M | 18 M | - | - | - | - | - | 1.37 M | 3.65 M | 4.17 M | - | - | - |
Retained Earnings |
-159 M | -137 M | -108 M | -88 M | -74.4 M | -66.7 M | -51.5 M | -54 M | -35.2 M | -22.3 M | -16.1 M | -46.7 M | -44.8 M |
Total Assets |
58.7 M | 50.1 M | 41.3 M | 34.6 M | 11.1 M | 9.25 M | 16.3 M | 18.7 M | 16.1 M | 13.6 M | 5.54 M | 227 K | 1.37 M |
Cash and Cash Equivalents |
14.7 M | 9.6 M | 34.9 M | 32.7 M | 3.9 M | 4.26 M | 6.14 M | 3.2 M | 5.57 M | 8.03 M | 1.73 M | 170 K | 1.04 M |
Book Value |
22.6 M | 11.8 M | 31.4 M | 28.2 M | 6.84 M | 4.62 M | 11.2 M | -4 M | -1.03 M | -6.25 M | -535 K | -167 K | 831 K |
Total Shareholders Equity |
22.6 M | 11.8 M | 31.4 M | 28.2 M | 6.84 M | 4.62 M | 11.2 M | -4 M | -1.03 M | -6.25 M | -535 K | 4.89 M | 1.66 M |
All numbers in USD currency
Quarterly Balance Sheet Capricor Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
835 K | 1.04 M | 1.25 M | 1.49 M | 1.68 M | 1.52 M | 1.7 M | 1.88 M | 2.08 M | 2.16 M | 2.31 M | 2.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
4.21 M | 4.42 M | 4.63 M | 4.86 M | 6.01 M | 8.13 M | 10.5 M | 14.7 M | 15.3 M | 19.8 M | 26 M | 5.83 M | 3.38 M | 3.38 M | 3.41 M | 3.45 M | 3.45 M | 3.45 M | 3.45 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 3.38 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 4.02 M | 4.02 M | 4.02 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
24.7 M | 26.8 M | 31 M | 36.1 M | 38.9 M | 43.3 M | 47.7 M | 38.3 M | 38.5 M | 39.3 M | 40.3 M | 9.96 M | 6.36 M | 6.55 M | 7.16 M | 6.42 M | 6.42 M | 6.42 M | 6.42 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 4.63 M | 4.63 M | 4.63 M | 4.63 M | 5.05 M | 5.05 M | 5.05 M | 5.05 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 6.07 M | 6.07 M | 6.07 M | 6.07 M | 529 K | 394 K | 394 K | 394 K | 541 K | 541 K | 541 K | - |
Deferred Revenue |
13.1 M | 15.4 M | 19.4 M | 24.3 M | 25.4 M | 29.3 M | 31 M | 18 M | 18.6 M | 15.7 M | 9.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 684 K | 1.37 M | 1.37 M | 1.37 M | 1.37 M | 3.65 M | 3.65 M | 3.65 M | 3.65 M | 4.17 M | 4.17 M | 4.17 M | 4.17 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-193 M | -180 M | -169 M | -159 M | -159 M | -152 M | -145 M | -137 M | -129 M | -123 M | -116 M | -108 M | -102 M | -97.9 M | -93.2 M | -88 M | -88 M | -88 M | -88 M | -74.4 M | -74.4 M | -74.4 M | -74.4 M | -66.7 M | -66.7 M | -66.7 M | -66.7 M | -51.5 M | -51.5 M | -51.5 M | -51.5 M | -54 M | -54 M | -54 M | -54 M | -35.2 M | -35.2 M | -35.2 M | -35.2 M | -22.3 M | -22.3 M | -22.3 M | -22.3 M | -16.1 M | -48.1 M | -47.8 M | -47.2 M | -46.7 M | -46.5 M | -46.7 M | -46.7 M | -44.8 M | -44.8 M | -44.8 M | -44.8 M |
Total Assets |
93 M | 38.3 M | 49.4 M | 58.7 M | 37.2 M | 46 M | 53.9 M | 50.1 M | 53.9 M | 58.1 M | 64.9 M | 41.3 M | 43.1 M | 39.9 M | 43.5 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 9.25 M | 9.25 M | 9.25 M | 9.25 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 5.54 M | 5.54 M | 5.54 M | 5.54 M | 5.42 M | 227 K | 227 K | 227 K | 1.37 M | 1.37 M | 1.37 M | 1.37 M |
Cash and Cash Equivalents |
68.4 M | 10.7 M | 6.21 M | 14.7 M | 8.98 M | 9.84 M | 10.6 M | 9.6 M | 8.41 M | 16.4 M | 58.3 M | 34.9 M | 40.8 M | 38.1 M | 41.9 M | 32.7 M | 32.7 M | 32.7 M | 32.7 M | 3.9 M | 3.9 M | 3.9 M | 3.9 M | 4.26 M | 4.26 M | 4.26 M | 4.26 M | 6.14 M | 6.14 M | 6.14 M | 6.14 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 5.57 M | 5.57 M | 5.57 M | 5.57 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 170 K | 46.7 K | 46.7 K | 46.7 K | 1.55 M | 1.04 M | 1.04 M | 1.04 M |
Book Value |
68.3 M | 11.5 M | 18.4 M | 22.6 M | -1.79 M | 2.73 M | 6.21 M | 11.8 M | 15.4 M | 18.7 M | 24.6 M | 31.4 M | 36.7 M | 33.4 M | 36.4 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 6.84 M | 6.84 M | 6.84 M | 6.84 M | 4.62 M | 4.62 M | 4.62 M | 4.62 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | -4 M | -4 M | -4 M | -4 M | -1.03 M | -1.03 M | -1.03 M | -1.03 M | -6.25 M | -6.25 M | -6.25 M | -6.25 M | -535 K | -535 K | -535 K | -535 K | 4.89 M | -167 K | -167 K | -167 K | 831 K | 831 K | 831 K | 1.37 M |
Total Shareholders Equity |
68.3 M | 11.5 M | 18.4 M | 22.6 M | -1.79 M | 2.73 M | 6.21 M | 11.8 M | 15.4 M | 18.7 M | 24.6 M | 31.4 M | 36.7 M | 33.4 M | 36.4 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 6.84 M | 6.84 M | 6.84 M | 6.84 M | 4.62 M | 4.62 M | 4.62 M | 4.62 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | -4 M | -4 M | -4 M | -4 M | -1.03 M | -1.03 M | -1.03 M | -1.03 M | -6.25 M | -6.25 M | -6.25 M | -6.25 M | -535 K | -535 K | -535 K | -535 K | 4.89 M | -167 K | -167 K | -167 K | 1.66 M | 831 K | 831 K | 831 K |
All numbers in USD currency